Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of egg coat	ZP1 ZP4	6.62e-05	5	52	2	GO:0035804
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRA1 LILRB1	6.62e-05	5	52	2	GO:0030107
GeneOntologyMolecularFunction	HLA-B specific inhibitory MHC class I receptor activity	LILRA1 LILRB1	9.91e-05	6	52	2	GO:0030109
GeneOntologyMolecularFunction	acrosin binding	ZP1 ZP4	9.91e-05	6	52	2	GO:0032190
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL4A1 ZP1 LAMA4 LAMC1 ZP4	1.27e-04	188	52	5	GO:0005201
GeneOntologyMolecularFunction	MHC class Ib protein complex binding	LILRA1 LILRB1	1.39e-04	7	52	2	GO:0023025
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO10 KIF13A DNAH6 DNAH9	2.52e-04	118	52	4	GO:0003774
GeneOntologyMolecularFunction	IgM binding	LILRA1 LILRB1	3.60e-04	11	52	2	GO:0001791
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	LILRA1 LILRB1	4.32e-04	12	52	2	GO:0032396
GeneOntologyMolecularFunction	MHC class Ib protein binding	LILRA1 LILRB1	7.80e-04	16	52	2	GO:0023029
GeneOntologyMolecularFunction	microtubule motor activity	KIF13A DNAH6 DNAH9	8.06e-04	70	52	3	GO:0003777
GeneOntologyMolecularFunction	coreceptor activity	LILRA1 IGSF1 LILRB1	8.75e-04	72	52	3	GO:0015026
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH6 DNAH9	9.91e-04	18	52	2	GO:0008569
GeneOntologyMolecularFunction	MHC class I receptor activity	LILRA1 LILRB1	9.91e-04	18	52	2	GO:0032393
GeneOntologyMolecularFunction	MHC class Ib receptor activity	LILRA1 LILRB1	1.11e-03	19	52	2	GO:0032394
GeneOntologyMolecularFunction	amyloid-beta binding	LILRA1 GRIA3 LILRB1	2.39e-03	102	52	3	GO:0001540
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH6 DNAH9	2.41e-03	28	52	2	GO:0051959
GeneOntologyMolecularFunction	chromatin binding	MTA2 MTA1 MTA3 NFATC1 ESR1 SVEP1 ZFY	2.90e-03	739	52	7	GO:0003682
GeneOntologyMolecularFunction	MHC class I protein binding	LILRA1 LILRB1	3.14e-03	32	52	2	GO:0042288
GeneOntologyMolecularFunction	protein phosphatase 1 binding	LILRA1 LILRB1	3.75e-03	35	52	2	GO:0008157
GeneOntologyMolecularFunction	immunoglobulin binding	LILRA1 LILRB1	3.96e-03	36	52	2	GO:0019865
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH6 DNAH9	4.18e-03	37	52	2	GO:0045505
GeneOntologyMolecularFunction	cell adhesion molecule binding	LILRA1 NRCAM PKP1 CDH19 LILRB1 SVEP1	4.49e-03	599	52	6	GO:0050839
GeneOntologyMolecularFunction	MHC protein complex binding	LILRA1 LILRB1	5.11e-03	41	52	2	GO:0023023
GeneOntologyBiologicalProcess	long-term synaptic potentiation	LILRA1 ENPP1 GRIA3 LILRB1 SHISA7	2.81e-05	144	51	5	GO:0060291
GeneOntologyBiologicalProcess	regulation of cell fate specification	MTA2 MTA1 MTA3	4.97e-05	29	51	3	GO:0042659
GeneOntologyCellularComponent	postsynaptic density membrane	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	2.50e-06	157	52	6	GO:0098839
GeneOntologyCellularComponent	CHD-type complex	MTA2 MTA1 MTA3	9.63e-06	17	52	3	GO:0090545
GeneOntologyCellularComponent	NuRD complex	MTA2 MTA1 MTA3	9.63e-06	17	52	3	GO:0016581
GeneOntologyCellularComponent	postsynaptic specialization membrane	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	1.03e-05	201	52	6	GO:0099634
GeneOntologyCellularComponent	synaptic cleft	LAMA4 LAMC1 GRIA3	7.51e-05	33	52	3	GO:0043083
GeneOntologyCellularComponent	egg coat	ZP1 ZP4	9.05e-05	6	52	2	GO:0035805
GeneOntologyCellularComponent	Fc-epsilon receptor I complex	LILRA1 LILRB1	2.16e-04	9	52	2	GO:0032998
GeneOntologyCellularComponent	Fc receptor complex	LILRA1 LILRB1	3.94e-04	12	52	2	GO:0032997
GeneOntologyCellularComponent	postsynaptic membrane	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	4.89e-04	405	52	6	GO:0045211
GeneOntologyCellularComponent	postsynaptic density	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	8.58e-04	451	52	6	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	1.15e-03	477	52	6	GO:0032279
GeneOntologyCellularComponent	histone deacetylase complex	MTA2 MTA1 MTA3	1.24e-03	85	52	3	GO:0000118
GeneOntologyCellularComponent	postsynaptic specialization	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	1.50e-03	503	52	6	GO:0099572
GeneOntologyCellularComponent	axonemal dynein complex	DNAH6 DNAH9	1.76e-03	25	52	2	GO:0005858
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	MTA2 MTA1 MTA3	1.76e-03	96	52	3	GO:0070603
GeneOntologyCellularComponent	neuron to neuron synapse	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	1.83e-03	523	52	6	GO:0098984
GeneOntologyCellularComponent	AMPA glutamate receptor complex	GRIA3 SHISA7	2.52e-03	30	52	2	GO:0032281
GeneOntologyCellularComponent	synaptic membrane	ABHD17B NRCAM PTPRS GRIA3 CSMD2 SHISA7	3.14e-03	583	52	6	GO:0097060
GeneOntologyCellularComponent	basement membrane	COL4A1 LAMA4 LAMC1	3.48e-03	122	52	3	GO:0005604
GeneOntologyCellularComponent	ATPase complex	MTA2 MTA1 MTA3	4.07e-03	129	52	3	GO:1904949
GeneOntologyCellularComponent	extracellular matrix	COL4A1 ZP1 LAMA4 LAMC1 ZP4 SVEP1	5.58e-03	656	52	6	GO:0031012
GeneOntologyCellularComponent	ionotropic glutamate receptor complex	GRIA3 SHISA7	5.61e-03	45	52	2	GO:0008328
GeneOntologyCellularComponent	external encapsulating structure	COL4A1 ZP1 LAMA4 LAMC1 ZP4 SVEP1	5.66e-03	658	52	6	GO:0030312
Domain	Myb_DNA-binding	MTA2 MTA1 ZZZ3 MTA3	2.43e-06	35	51	4	PF00249
Domain	BAH	MTA2 MTA1 MTA3	3.12e-06	11	51	3	SM00439
Domain	BAH	MTA2 MTA1 MTA3	3.12e-06	11	51	3	PF01426
Domain	BAH	MTA2 MTA1 MTA3	3.12e-06	11	51	3	PS51038
Domain	BAH_dom	MTA2 MTA1 MTA3	3.12e-06	11	51	3	IPR001025
Domain	ZnF_GATA	MTA2 MTA1 MTA3	4.15e-06	12	51	3	SM00401
Domain	ELM2	MTA2 MTA1 MTA3	5.38e-06	13	51	3	PF01448
Domain	ELM2	MTA2 MTA1 MTA3	5.38e-06	13	51	3	PS51156
Domain	ELM2_dom	MTA2 MTA1 MTA3	5.38e-06	13	51	3	IPR000949
Domain	ELM2	MTA2 MTA1 MTA3	5.38e-06	13	51	3	SM01189
Domain	Znf_GATA	MTA2 MTA1 MTA3	8.53e-06	15	51	3	IPR000679
Domain	GATA	MTA2 MTA1 MTA3	8.53e-06	15	51	3	PF00320
Domain	SANT	MTA2 MTA1 ZZZ3 MTA3	1.04e-05	50	51	4	SM00717
Domain	GATA_ZN_FINGER_1	MTA2 MTA1 MTA3	1.05e-05	16	51	3	PS00344
Domain	GATA_ZN_FINGER_2	MTA2 MTA1 MTA3	1.05e-05	16	51	3	PS50114
Domain	SANT/Myb	MTA2 MTA1 ZZZ3 MTA3	1.21e-05	52	51	4	IPR001005
Domain	SANT_dom	MTA2 MTA1 MTA3	4.77e-05	26	51	3	IPR017884
Domain	SANT	MTA2 MTA1 MTA3	5.99e-05	28	51	3	PS51293
Domain	MYB_LIKE	MTA2 MTA1 MTA3	1.51e-04	38	51	3	PS50090
Domain	ig	LILRA1 NRCAM PTPRS IGSF1 LILRB1	1.66e-04	190	51	5	PF00047
Domain	Immunoglobulin	LILRA1 NRCAM PTPRS IGSF1 LILRB1	1.66e-04	190	51	5	IPR013151
Domain	P_TREFOIL_1	ZP1 ZP4	2.03e-04	8	51	2	PS00025
Domain	P_trefoil_CS	ZP1 ZP4	2.03e-04	8	51	2	IPR017957
Domain	P_TREFOIL_2	ZP1 ZP4	2.60e-04	9	51	2	PS51448
Domain	PD	ZP1 ZP4	2.60e-04	9	51	2	SM00018
Domain	Homeodomain-like	MTA2 HOXA6 HOXC5 MTA1 ZZZ3 MTA3	2.77e-04	332	51	6	IPR009057
Domain	ZP_dom_CS	ZP1 ZP4	3.24e-04	10	51	2	IPR017977
Domain	Sushi	CSMD2 SVEP1 F13B	3.86e-04	52	51	3	PF00084
Domain	-	ZP1 ZP4	3.96e-04	11	51	2	4.10.110.10
Domain	CCP	CSMD2 SVEP1 F13B	4.31e-04	54	51	3	SM00032
Domain	IGc2	LILRA1 NRCAM PTPRS IGSF1 LILRB1	4.43e-04	235	51	5	SM00408
Domain	Ig_sub2	LILRA1 NRCAM PTPRS IGSF1 LILRB1	4.43e-04	235	51	5	IPR003598
Domain	P_trefoil_dom	ZP1 ZP4	4.74e-04	12	51	2	IPR000519
Domain	Homeobox_antennapedia	HOXA6 HOXC5	4.74e-04	12	51	2	IPR017995
Domain	SUSHI	CSMD2 SVEP1 F13B	4.80e-04	56	51	3	PS50923
Domain	Sushi_SCR_CCP_dom	CSMD2 SVEP1 F13B	5.06e-04	57	51	3	IPR000436
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DNAH9	6.51e-04	14	51	2	IPR024317
Domain	ZP_1	ZP1 ZP4	6.51e-04	14	51	2	PS00682
Domain	Dynein_HC_stalk	DNAH6 DNAH9	6.51e-04	14	51	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH6 DNAH9	6.51e-04	14	51	2	IPR013602
Domain	DHC_N2	DNAH6 DNAH9	6.51e-04	14	51	2	PF08393
Domain	MT	DNAH6 DNAH9	6.51e-04	14	51	2	PF12777
Domain	AAA_8	DNAH6 DNAH9	6.51e-04	14	51	2	PF12780
Domain	ZP_2	ZP1 ZP4	6.51e-04	14	51	2	PS51034
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH9	6.51e-04	14	51	2	IPR011704
Domain	AAA_5	DNAH6 DNAH9	6.51e-04	14	51	2	PF07728
Domain	DHC_fam	DNAH6 DNAH9	7.50e-04	15	51	2	IPR026983
Domain	Dynein_heavy_dom	DNAH6 DNAH9	7.50e-04	15	51	2	IPR004273
Domain	Dynein_heavy	DNAH6 DNAH9	7.50e-04	15	51	2	PF03028
Domain	ZP	ZP1 ZP4	7.50e-04	15	51	2	SM00241
Domain	ZP_dom	ZP1 ZP4	9.68e-04	17	51	2	IPR001507
Domain	Zona_pellucida	ZP1 ZP4	9.68e-04	17	51	2	PF00100
Domain	Ig_2	LILRA1 IGSF1 LILRB1	1.04e-03	73	51	3	PF13895
Domain	Homeobox_Antennapedia_CS	HOXA6 HOXC5	1.49e-03	21	51	2	IPR001827
Domain	ANTENNAPEDIA	HOXA6 HOXC5	1.94e-03	24	51	2	PS00032
Domain	EGF_LAM_2	LAMA4 LAMC1	3.03e-03	30	51	2	PS50027
Domain	EGF_LAM_1	LAMA4 LAMC1	3.03e-03	30	51	2	PS01248
Domain	Alkaline_phosphatase_core	ENPP1 ARSI	3.23e-03	31	51	2	IPR017850
Domain	Alkaline_Pase-like_a/b/a	ENPP1 ARSI	3.23e-03	31	51	2	IPR017849
Domain	-	ENPP1 ARSI	3.23e-03	31	51	2	3.40.720.10
Domain	EGF	DLL4 LAMA4 LAMC1 SVEP1	3.84e-03	235	51	4	SM00181
Domain	Laminin_EGF	LAMA4 LAMC1	4.11e-03	35	51	2	PF00053
Domain	EGF_Lam	LAMA4 LAMC1	4.11e-03	35	51	2	SM00180
Domain	ANF_lig-bd_rcpt	TAS1R3 GRIA3	4.58e-03	37	51	2	IPR001828
Domain	ANF_receptor	TAS1R3 GRIA3	4.58e-03	37	51	2	PF01094
Pathway	BIOCARTA_MTA3_PATHWAY	MTA1 MTA3 ESR1	1.55e-05	18	39	3	M225
Pathway	BIOCARTA_MTA3_PATHWAY	MTA1 MTA3 ESR1	2.16e-05	20	39	3	MM1383
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	MTA2 MTA1 MTA3	5.47e-05	27	39	3	MM15537
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL4A1 PTPRS LAMA4 LAMC1	5.56e-05	76	39	4	M27219
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A1 LAMA4 LAMC1	7.55e-05	30	39	3	M27216
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION	MTA2 MTA1 MTA3	8.34e-05	31	39	3	M48258
Pathway	WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA	MTA2 MTA1 MTA3	1.43e-04	37	39	3	M39756
Pathway	KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	DLL4 ESR1	1.55e-04	7	39	2	M47805
Pathway	WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS	COL4A1 LAMA4 LAMC1	2.24e-04	43	39	3	M39565
Pathway	PID_INTEGRIN3_PATHWAY	COL4A1 LAMA4 LAMC1	2.24e-04	43	39	3	M53
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	MTA2 MTA1 MTA3	2.92e-04	47	39	3	M1095
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	MTA2 MTA1 MTA3	2.92e-04	47	39	3	MM15428
Pathway	BIOCARTA_NPP1_PATHWAY	COL4A1 ENPP1	3.31e-04	10	39	2	M22040
Pathway	BIOCARTA_NPP1_PATHWAY	COL4A1 ENPP1	3.31e-04	10	39	2	MM1560
Pathway	REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA	ZP1 ZP4	4.04e-04	11	39	2	M27184
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	MTA2 MTA1 MTA3	4.65e-04	55	39	3	MM14932
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL4A1 LAMA4 LAMC1	5.72e-04	59	39	3	M27218
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	MTA2 MTA1 MTA3 ESR1 RICTOR	6.15e-04	252	39	5	MM15585
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	MTA2 MTA1 MTA3	6.31e-04	61	39	3	M27811
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A1 LAMA4	7.65e-04	15	39	2	MM14922
Pathway	PID_INTEGRIN1_PATHWAY	COL4A1 LAMA4 LAMC1	7.94e-04	66	39	3	M18
Pathway	REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION	MTA2 MTA1 MTA3	1.15e-03	75	39	3	M27343
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	MTA2 MTA1 PTPRS EWSR1 ZFY	1.36e-03	301	39	5	MM15983
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	PTPRS GRIA3	1.37e-03	20	39	2	MM15485
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	PTPRS GRIA3	1.52e-03	21	39	2	M27736
Pathway	KEGG_SMALL_CELL_LUNG_CANCER	COL4A1 LAMA4 LAMC1	1.60e-03	84	39	3	M3228
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	COL4A1 LAMA4 LAMC1	1.60e-03	84	39	3	M7098
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	MTA2 MTA1 MTA3 ESR1 RICTOR	1.62e-03	313	39	5	M27867
Pathway	WP_TCELL_ACTIVATION_SARSCOV2	RASGRP1 NFATC1 RICTOR	1.83e-03	88	39	3	M42580
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	MTA2 MTA1 MTA3	2.21e-03	94	39	3	M27230
Pathway	REACTOME_FERTILIZATION	ZP1 ZP4	2.32e-03	26	39	2	M26922
Pathway	WP_SMALL_CELL_LUNG_CANCER	COL4A1 LAMA4 LAMC1	2.34e-03	96	39	3	M39834
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	MTA2 MTA1 MTA3	2.41e-03	97	39	3	M48262
Pathway	REACTOME_PTEN_REGULATION	MTA2 MTA1 MTA3	2.48e-03	98	39	3	MM15348
Pathway	WP_CANCER_PATHWAYS	COL4A1 RASGRP1 DLL4 ESR1 LAMA4 LAMC1	2.50e-03	507	39	6	M48302
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH6 DNAH9	2.51e-03	27	39	2	M47755
Pubmed	Identification and characterization of metastasis-associated gene/protein 1 (MTA1).	MTA2 MTA1 MTA3	3.34e-09	3	53	3	25315816
Pubmed	Structure, expression and functions of MTA genes.	MTA2 MTA1 MTA3	3.34e-09	3	53	3	26869315
Pubmed	Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.	MTA1 MTA3 ESR1	3.33e-08	5	53	3	16502042
Pubmed	The Nucleosome Remodelling and Deacetylation complex suppresses transcriptional noise during lineage commitment.	MTA2 MTA1 MTA3	3.33e-08	5	53	3	31036553
Pubmed	NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1.	LILRA1 NFATC1 LILRB1	1.16e-07	7	53	3	27897222
Pubmed	The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex.	MTA2 MTA1 MTA3	1.86e-07	8	53	3	18067919
Pubmed	Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.	MTA2 MTA1 MTA3	2.79e-07	9	53	3	26028330
Pubmed	RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene.	MTA2 MTA1 MTA3	2.79e-07	9	53	3	22926524
Pubmed	PWWP2B Fine-Tunes Adipose Thermogenesis by Stabilizing HDACs in a NuRD Subcomplex.	MTA2 MTA1 MTA3	3.98e-07	10	53	3	34180153
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	MTA2 MTA1 MTA3	7.28e-07	12	53	3	22560079
Pubmed	Metastasis tumor antigen 2 (MTA2) is involved in proper imprinted expression of H19 and Peg3 during mouse preimplantation development.	MTA2 MTA1 MTA3	7.28e-07	12	53	3	20720167
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	MTA2 MTA1 MTA3	9.45e-07	13	53	3	19703393
Pubmed	The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut.	COL4A1 LAMA4 LAMC1	9.45e-07	13	53	3	36350252
Pubmed	Basement membranes in skin are differently affected by lack of nidogen 1 and 2.	COL4A1 LAMA4 LAMC1	9.45e-07	13	53	3	18356808
Pubmed	The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.	MTA2 MTA1 MTA3	9.45e-07	13	53	3	12920132
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	MTA2 HOXA6 HOXC5 MTA1 ZZZ3 MTA3 ESR1 EWSR1 ZFY	1.15e-06	709	53	9	22988430
Pubmed	MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.	MTA2 MTA1 MTA3	1.20e-06	14	53	3	16428440
Pubmed	NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.	MTA2 MTA1 MTA3	1.20e-06	14	53	3	25150861
Pubmed	Basement membrane composition in the early mouse embryo day 7.	COL4A1 LAMA4 LAMC1	1.50e-06	15	53	3	15895400
Pubmed	The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.	MTA2 MTA1 MTA3	1.50e-06	15	53	3	25247294
Pubmed	Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane.	COL4A1 LAMA4 LAMC1	1.50e-06	15	53	3	10625553
Pubmed	NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development.	MTA2 MTA1 MTA3	1.50e-06	15	53	3	19927129
Pubmed	ENPP1 and ESR1 genotypes associated with subclassifications of craniofacial asymmetry and severity of temporomandibular disorders.	ENPP1 ESR1	2.28e-06	2	53	2	29103441
Pubmed	Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.	MTA3 ESR1	2.28e-06	2	53	2	15169784
Pubmed	The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.	MTA1 MTA3	2.28e-06	2	53	2	19363681
Pubmed	A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.	MTA1 ESR1	2.28e-06	2	53	2	12167865
Pubmed	Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation.	MTA2 MTA1	2.28e-06	2	53	2	30642362
Pubmed	Assignment of the metastasis-associated gene (Mta1) to mouse chromosome band 12F and the metastasis-associated gene 2 (Mta2) to mouse chromosome band 19B by fluorescence in situ hybridization.	MTA2 MTA1	2.28e-06	2	53	2	11856890
Pubmed	Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s.	MTA1 ESR1	2.28e-06	2	53	2	16807247
Pubmed	Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.	MTA1 MTA3	2.28e-06	2	53	2	25319202
Pubmed	Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis.	MTA1 ESR1	2.28e-06	2	53	2	26503703
Pubmed	Estrogen receptor and laminin genetic polymorphism among women with pelvic organ prolapse.	ESR1 LAMC1	2.28e-06	2	53	2	29241914
Pubmed	Four zona pellucida glycoproteins are expressed in the human.	ZP1 ZP4	2.28e-06	2	53	2	15142998
Pubmed	Interaction of estrogen receptor alpha transactivation domain with MTA1 decreases in old mouse brain.	MTA1 ESR1	2.28e-06	2	53	2	18679832
Pubmed	Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells.	MTA2 MTA3	2.28e-06	2	53	2	33744762
Pubmed	Laminin γ-1 and collagen α-1 (VI) chain are galactose-α-1,3-galactose-bound allergens in beef.	COL4A1 LAMC1	2.28e-06	2	53	2	24180678
Pubmed	ENPP1 and ESR1 genotypes influence temporomandibular disorders development and surgical treatment response in dentofacial deformities.	ENPP1 ESR1	2.28e-06	2	53	2	27519661
Pubmed	Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development.	MTA2 MTA1 MTA3	2.68e-06	18	53	3	23201013
Pubmed	The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.	MTA2 MTA1 MTA3	2.68e-06	18	53	3	9790534
Pubmed	Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.	MTA2 MTA1 MTA3	2.68e-06	18	53	3	10444591
Pubmed	FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.	MTA2 MTA1 MTA3	3.74e-06	20	53	3	27773593
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	MTA2 MTA1 MTA3 DNAH9	5.39e-06	75	53	4	25593309
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MTA2 MTA1 ZZZ3 MTA3 EWSR1	5.73e-06	167	53	5	20362541
Pubmed	Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4.	LILRA1 LILRB1	6.83e-06	3	53	2	10941837
Pubmed	Estrogen receptor alpha and NFATc1 bind to a bone mineral density-associated SNP to repress WNT5B in osteoblasts.	NFATC1 ESR1	6.83e-06	3	53	2	34906330
Pubmed	Neuroprotective effects of a chromatin modifier on ischemia/reperfusion neurons: implication of its regulation of BCL2 transactivation by ERα signaling.	MTA1 ESR1	6.83e-06	3	53	2	26728277
Pubmed	Correlation of extracellular matrix-related gene expression with objective Fuchs endothelial corneal dystrophy severity.	COL4A1 LAMC1	6.83e-06	3	53	2	30578652
Pubmed	Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.	MTA1 ESR1	6.83e-06	3	53	2	15254226
Pubmed	Differential expression of laminin, nidogen and collagen IV genes in the midgestation mouse placenta.	COL4A1 LAMC1	6.83e-06	3	53	2	8153091
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	COL4A1 LAMA4 LAMC1	8.47e-06	26	53	3	24742657
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	MTA2 MTA1 MTA3 NFATC1 MYO10 EWSR1	9.40e-06	321	53	6	32098917
Pubmed	Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo.	DLL4 LAMA4	1.36e-05	4	53	2	21979816
Pubmed	Embryo implantation triggers dynamic spatiotemporal expression of the basement membrane toolkit during uterine reprogramming.	COL4A1 LAMC1	1.36e-05	4	53	2	27619726
Pubmed	Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146).	LAMA4 LAMC1	1.36e-05	4	53	2	24951930
Pubmed	Zona Pellucida Proteins, Fibrils, and Matrix.	ZP1 ZP4	1.36e-05	4	53	2	32569527
Pubmed	ZP2 pathogenic variants cause in vitro fertilization failure and female infertility.	ZP1 ZP4	1.36e-05	4	53	2	29895852
Pubmed	Immunohistochemical localization of zona pellucida proteins ZPA, ZPB and ZPC in human, cynomolgus monkey and mouse ovaries.	ZP1 ZP4	1.36e-05	4	53	2	11291774
Pubmed	LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.	LILRA1 LILRB1	1.36e-05	4	53	2	21559424
Pubmed	Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.	MTA1 ESR1	1.36e-05	4	53	2	11146623
Pubmed	Developmentally regulated expression of type XV collagen correlates with abnormalities in Col15a1(-/-) mice.	COL4A1 LAMC1	1.36e-05	4	53	2	11827796
Pubmed	Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.	COL4A1 ESR1	1.36e-05	4	53	2	15467744
Pubmed	Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.	LAMA4 LAMC1	1.36e-05	4	53	2	16146715
Pubmed	HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.	LILRA1 LILRB1	1.36e-05	4	53	2	21270408
Pubmed	Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.	DNAH6 DNAH9	1.36e-05	4	53	2	11175280
Pubmed	PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.	MTA2 MTA1 MTA3	1.46e-05	31	53	3	29846670
Pubmed	Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.	LILRA1 LILRB1	2.27e-05	5	53	2	18787130
Pubmed	PIR-B Regulates CD4+ IL17a+ T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses.	LILRA1 LILRB1	2.27e-05	5	53	2	34242819
Pubmed	The LILR family: modulators of innate and adaptive immune pathways in health and disease.	LILRA1 LILRB1	2.27e-05	5	53	2	15304001
Pubmed	Role of PIR-B in autoimmune glomerulonephritis.	LILRA1 LILRB1	2.27e-05	5	53	2	20976309
Pubmed	TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells.	MTA2 ESR1	2.27e-05	5	53	2	22457607
Pubmed	Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury.	LILRA1 LILRB1	2.27e-05	5	53	2	20881122
Pubmed	The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.	MTA2 MTA1	2.27e-05	5	53	2	16462733
Pubmed	PirB Overexpression Exacerbates Neuronal Apoptosis by Inhibiting TrkB and mTOR Phosphorylation After Oxygen and Glucose Deprivation Injury.	LILRA1 LILRB1	2.27e-05	5	53	2	27443384
Pubmed	The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling.	LILRA1 LILRB1	2.27e-05	5	53	2	15494528
Pubmed	Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses.	LILRA1 LILRB1	2.27e-05	5	53	2	19684158
Pubmed	Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.	MTA1 ESR1	2.27e-05	5	53	2	14722073
Pubmed	PirB negatively regulates the inflammatory activation of astrocytes in a mouse model of sleep deprivation.	LILRA1 LILRB1	2.27e-05	5	53	2	37146940
Pubmed	PirB functions as an intrinsic suppressor in hippocampal neural stem cells.	LILRA1 LILRB1	2.27e-05	5	53	2	34120891
Pubmed	PirB regulates a structural substrate for cortical plasticity.	LILRA1 LILRB1	2.27e-05	5	53	2	24302763
Pubmed	Spatio-temporal expression of paired immunoglobulin-like receptor-B in the adult mouse brain after focal cerebral ischaemia.	LILRA1 LILRB1	2.27e-05	5	53	2	23927735
Pubmed	Enhancing motor learning by increasing the stability of newly formed dendritic spines in the motor cortex.	LILRA1 LILRB1	2.27e-05	5	53	2	34437845
Pubmed	Genes coding for basement membrane glycoproteins laminin, nidogen, and collagen IV are differentially expressed in the nervous system and by epithelial, endothelial, and mesenchymal cells of the mouse embryo.	COL4A1 LAMC1	2.27e-05	5	53	2	8359228
Pubmed	Cloning and characterization of zona pellucida genes and cDNAs from a variety of mammalian species: the ZPA, ZPB and ZPC gene families.	ZP1 ZP4	2.27e-05	5	53	2	7841460
Pubmed	Expression of collagen alpha 1(IV), laminin and nidogen genes in the embryonic mouse lung: implications for branching morphogenesis.	COL4A1 LAMC1	2.27e-05	5	53	2	7516699
Pubmed	Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus.	LILRA1 LILRB1	2.27e-05	5	53	2	37147336
Pubmed	Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.	LILRA1 LILRB1	2.27e-05	5	53	2	33653799
Pubmed	Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.	MTA2 ESR1	2.27e-05	5	53	2	16645043
Pubmed	Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury.	LILRA1 LILRB1	2.27e-05	5	53	2	21087927
Pubmed	Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis.	LILRA1 LILRB1	2.27e-05	5	53	2	20398663
Pubmed	Structure and flexibility of the extracellular region of the PirB receptor.	LILRA1 LILRB1	2.27e-05	5	53	2	30674550
Pubmed	Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence.	LILRA1 LILRB1	2.27e-05	5	53	2	23152562
Pubmed	Regulation of plasmacytoid dendritic cell responses by PIR-B.	LILRA1 LILRB1	2.27e-05	5	53	2	22948046
Pubmed	Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors.	LILRA1 LILRB1	2.27e-05	5	53	2	9054430
Pubmed	Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.	LILRA1 LILRB1	2.27e-05	5	53	2	10359805
Pubmed	Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.	LILRA1 LILRB1	2.27e-05	5	53	2	27324131
Pubmed	Characterization of paired Ig-like receptors in rats.	LILRA1 LILRB1	2.27e-05	5	53	2	10586026
Pubmed	Paired immunoglobulin-like receptor B regulates platelet activation.	LILRA1 LILRB1	2.27e-05	5	53	2	25075127
Pubmed	Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.	MTA1 ESR1	2.27e-05	5	53	2	16288053
Pubmed	Genomic structure of PIR-B, the inhibitory member of the paired immunoglobulin-like receptor genes in mice.	LILRA1 LILRB1	2.27e-05	5	53	2	9550322
Pubmed	Expression of PirB protein in intact and injured optic nerve and retina of mice.	LILRA1 LILRB1	2.27e-05	5	53	2	22102155
Interaction	TRPS1 interactions	MTA2 MTA1 MTA3 NFATC1 ESR1 RICTOR EWSR1	8.01e-08	143	52	7	int:TRPS1
Interaction	LILRA3 interactions	LILRA1 EWSR1 LILRB1	2.63e-06	11	52	3	int:LILRA3
Interaction	HMGXB4 interactions	MTA2 MTA1 MTA3 ESR1 RICTOR	1.07e-05	113	52	5	int:HMGXB4
Interaction	GATAD1 interactions	MTA2 MTA1 MTA3 ESR1 RICTOR	2.19e-05	131	52	5	int:GATAD1
Interaction	ATF7IP interactions	LAMA4 LAMC1 EWSR1 KIF13A SVEP1	2.81e-05	138	52	5	int:ATF7IP
Interaction	GATAD2B interactions	MTA2 MTA1 MTA3 NFATC1 ESR1 RICTOR	3.87e-05	245	52	6	int:GATAD2B
Interaction	BCL11B interactions	MTA2 MTA1 MTA3 NFATC1	3.97e-05	74	52	4	int:BCL11B
Interaction	ZBTB7B interactions	MTA2 MTA1 MTA3 NFATC1 MYO10 ESR1 EWSR1	4.08e-05	366	52	7	int:ZBTB7B
Interaction	PHF20L1 interactions	MTA2 MTA1 ZZZ3 MTA3	4.18e-05	75	52	4	int:PHF20L1
Interaction	PWWP2A interactions	MTA2 MTA1 MTA3 ESR1	4.41e-05	76	52	4	int:PWWP2A
Interaction	ZFPM2 interactions	MTA2 MTA1 MTA3	5.07e-05	28	52	3	int:ZFPM2
Interaction	ZNF827 interactions	MTA2 MTA1 MTA3	5.65e-05	29	52	3	int:ZNF827
Interaction	SALL4 interactions	MTA2 MTA1 MTA3 EWSR1	6.23e-05	83	52	4	int:SALL4
Interaction	TCF19 interactions	MTA2 MTA1 MTA3	7.62e-05	32	52	3	int:TCF19
Interaction	LIN37 interactions	MTA2 MTA1 MTA3 EWSR1	9.71e-05	93	52	4	int:LIN37
Interaction	TFCP2L1 interactions	MTA2 MTA1 ZZZ3 MTA3	1.24e-04	99	52	4	int:TFCP2L1
Interaction	ZMYND8 interactions	MTA2 MTA1 MTA3 ESR1 DNAH9	1.31e-04	191	52	5	int:ZMYND8
Interaction	ZNF800 interactions	MTA2 MTA3 ESR1	1.50e-04	40	52	3	int:ZNF800
Interaction	BACC1 interactions	MTA2 MTA1 MTA3 ESR1	1.50e-04	104	52	4	int:BACC1
Interaction	MBD3L2 interactions	MTA2 MTA1 MTA3	1.61e-04	41	52	3	int:MBD3L2
Interaction	LIPK interactions	ABHD17B LAMC1	1.81e-04	8	52	2	int:LIPK
Interaction	BUD13 interactions	MTA2 MTA1 MTA3 ESR1	1.86e-04	110	52	4	int:BUD13
Interaction	LIN9 interactions	MTA2 MTA1 MTA3 ESR1	1.92e-04	111	52	4	int:LIN9
Interaction	HAT1 interactions	MTA2 MTA1 MTA3 ESR1 RICTOR	2.38e-04	217	52	5	int:HAT1
Interaction	MTF2 interactions	MTA2 MTA1 MTA3 EWSR1	2.43e-04	118	52	4	int:MTF2
Interaction	CDK2AP1 interactions	MTA2 MTA1 MTA3 ESR1	2.43e-04	118	52	4	int:CDK2AP1
Interaction	NACC2 interactions	MTA2 MTA1 MTA3	2.58e-04	48	52	3	int:NACC2
Interaction	CDK2AP2 interactions	MTA2 MTA1 MTA3	2.75e-04	49	52	3	int:CDK2AP2
Interaction	ERCC6 interactions	MTA2 MTA1 MTA3 ESR1 FECH	2.76e-04	224	52	5	int:ERCC6
Interaction	HMG20B interactions	MTA2 MTA1 MTA3 ESR1	2.76e-04	122	52	4	int:HMG20B
Interaction	FOXK2 interactions	MTA2 MTA1 MTA3 NFATC1 ESR1	2.81e-04	225	52	5	int:FOXK2
Interaction	POU4F1 interactions	ESR1 EWSR1	2.90e-04	10	52	2	int:POU4F1
Interaction	FAM219A interactions	MTA2 MTA1 MTA3	2.92e-04	50	52	3	int:FAM219A
Interaction	LIN52 interactions	MTA2 MTA1 MTA3	3.09e-04	51	52	3	int:LIN52
Interaction	L3MBTL2 interactions	MTA2 MTA1 MTA3 CDH19 ZFY	3.18e-04	231	52	5	int:L3MBTL2
Interaction	FHL1 interactions	ESR1 LAMA4 RICTOR EWSR1	3.42e-04	129	52	4	int:FHL1
Interaction	FKBP3 interactions	MTA2 ESR1 RICTOR EWSR1	3.63e-04	131	52	4	int:FKBP3
Cytoband	Xq25	GRIA3 IGSF1	1.04e-03	41	53	2	Xq25
Cytoband	15q14	RASGRP1 DLL4	1.49e-03	49	53	2	15q14
GeneFamily	PHD finger proteins\|NuRD complex	MTA2 MTA1 MTA3	2.53e-06	12	42	3	1305
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA2 MTA1 MTA3	5.20e-06	15	42	3	82
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA2 MTA1 ZZZ3 MTA3	6.78e-06	53	42	4	532
GeneFamily	Zona pellucida glycoproteins	ZP1 ZP4	3.15e-05	4	42	2	8
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 SVEP1 F13B	3.13e-04	57	42	3	1179
GeneFamily	Laminin subunits	LAMA4 LAMC1	3.43e-04	12	42	2	626
GeneFamily	Dyneins, axonemal	DNAH6 DNAH9	7.01e-04	17	42	2	536
GeneFamily	HOXL subclass homeoboxes	HOXA6 HOXC5	6.49e-03	52	42	2	518
Coexpression	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN	HOXC5 NRCAM MYO10 PKP1 LAMA4 GRIA3	2.70e-06	199	52	6	M3653
Coexpression	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	RASGRP1 LILRA1 NRCAM LAMC1 LILRB1	1.59e-05	159	52	5	M12138
Coexpression	NABA_CORE_MATRISOME	COL4A1 ZP1 LAMA4 LAMC1 ZP4 SVEP1	1.72e-05	275	52	6	M5884
Coexpression	GSE37301_PRO_BCELL_VS_CD4_TCELL_DN	ZZZ3 MYO10 ESR1 EWSR1 SVEP1	1.90e-05	165	52	5	M8907
Coexpression	LIM_MAMMARY_STEM_CELL_UP	ELOVL4 COL4A1 NRCAM PKP1 LAMC1 ARSI SVEP1	4.28e-05	479	52	7	M2573
Coexpression	GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	COL4A1 ENPP1 LAMC1 GRIA3 CDH19	4.34e-05	196	52	5	M8135
Coexpression	NABA_ECM_GLYCOPROTEINS	ZP1 LAMA4 LAMC1 ZP4 SVEP1	4.34e-05	196	52	5	M3008
Coexpression	GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP	HOXC5 MYO10 LAMA4 LAMC1 IGSF1	4.45e-05	197	52	5	M8426
Coexpression	LIM_MAMMARY_STEM_CELL_UP	ELOVL4 COL4A1 NRCAM PKP1 LAMC1 ARSI SVEP1	4.51e-05	483	52	7	MM1082
Coexpression	GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN	HOXC5 NRCAM PKP1 LAMA4 GRIA3	4.78e-05	200	52	5	M3640
Coexpression	NABA_BASEMENT_MEMBRANES	COL4A1 LAMA4 LAMC1	6.91e-05	40	52	3	M5887
Coexpression	TRAVAGLINI_LUNG_PERICYTE_CELL	COL4A1 NRCAM MYO10 CDH19	7.82e-05	114	52	4	M41678
Coexpression	KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP	ELOVL4 RASGRP1 ZZZ3 CLTCL1 CEP41	8.52e-05	226	52	5	M40962
Coexpression	NABA_CORE_MATRISOME	COL4A1 ZP1 LAMA4 LAMC1 SVEP1	1.96e-04	270	52	5	MM17057
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22	CLTCL1 EWSR1	2.10e-04	11	52	2	M11594
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A1 HOXA6 ZP1 NRCAM MYO10 CDH19 ARSI	1.85e-09	179	53	7	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL4A1 NRCAM MYO10 LAMA4 LAMC1 ARSI SVEP1	3.87e-09	199	53	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 GRIA3 CSMD2 CDH19 KIF13A SHISA7	3.05e-08	155	53	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL4A1 NRCAM MYO10 KLHL23 CDH19 PDZRN4	8.17e-08	183	53	6	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 ZP1 PTPRS LAMA4 LAMC1 SVEP1	8.99e-08	186	53	6	7582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	COL4A1 NRCAM KLHL23 LAMA4 CDH19 PDZRN4	9.28e-08	187	53	6	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	COL4A1 NRCAM MYO10 LAMA4 LAMC1 CDH19	9.89e-08	189	53	6	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM PTPRS MYO10 LAMA4 ARSI SVEP1	9.89e-08	189	53	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A1 NRCAM MYO10 KLHL23 LAMA4 CDH19	1.02e-07	190	53	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A1 NRCAM MYO10 KLHL23 LAMA4 CDH19	1.02e-07	190	53	6	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	COL4A1 PTPRS LAMC1 CDH19 SVEP1 PDZRN4	1.15e-07	194	53	6	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	NRCAM PTPRS MYO10 LAMA4 LAMC1 SVEP1	1.19e-07	195	53	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Adult-Appendix\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 NFATC1 PTPRS LAMA4 LAMC1 SVEP1	1.23e-07	196	53	6	a579211ef14f348d0c5a290553150222dfbf1515
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	COL4A1 PTPRS LAMA4 LAMC1 CSMD2 SVEP1	1.26e-07	197	53	6	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL4A1 NRCAM MYO10 LAMA4 ARSI SVEP1	1.34e-07	199	53	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NRCAM KLHL23 LAMA4 CDH19 PDZRN4	1.34e-07	199	53	6	929f809579368201331d9099d8904b6e3c41797b
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NRCAM KLHL23 LAMA4 CDH19 PDZRN4	1.34e-07	199	53	6	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A1 NRCAM LAMA4 LAMC1 ARSI SVEP1	1.38e-07	200	53	6	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 ENPP1 LAMA4 LAMC1 SVEP1 PDZRN4	1.38e-07	200	53	6	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	distal-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A1 NRCAM MYO10 KLHL23 CDH19 ARSI	1.38e-07	200	53	6	4ee0b2f56c2652435fa78bf6b3c90cea28df74e0
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	DLL4 PTPRS LAMA4 ARSI SVEP1	1.29e-06	159	53	5	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	COL4A1 NRCAM KLHL23 LAMA4 CDH19	1.85e-06	171	53	5	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	ELOVL4 COL4A1 NRCAM LAMA4 CDH19	1.91e-06	172	53	5	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL4A1 NRCAM LAMA4 CDH19 PDZRN4	1.96e-06	173	53	5	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A1 NRCAM MYO10 KLHL23 CDH19	2.25e-06	178	53	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B_plasma\|GI_small-bowel / Manually curated celltypes from each tissue	DLL4 PTPRS TAS1R3 ESR1 LAMC1	2.45e-06	181	53	5	9b33f531c8ac776706ec7e2d47e95ba30b6ce13c
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A1 NRCAM MYO10 KLHL23 CDH19	2.45e-06	181	53	5	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells\|GI_small-bowel / Manually curated celltypes from each tissue	DLL4 PTPRS TAS1R3 ESR1 LAMC1	2.45e-06	181	53	5	a0549a8c2b5b30e91fae3052f398e48baa45d7ff
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 PTPRS LAMC1 CSMD2 SVEP1	2.72e-06	185	53	5	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A1 NRCAM MYO10 KLHL23 CDH19	2.87e-06	187	53	5	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	PTPRS MYO10 LAMA4 LAMC1 SVEP1	2.87e-06	187	53	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	COL4A1 NRCAM MYO10 KLHL23 CDH19	2.87e-06	187	53	5	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRS ESR1 LAMA4 SVEP1 PDZRN4	2.95e-06	188	53	5	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NRCAM PTPRS LAMA4 GRIA3 SVEP1	2.95e-06	188	53	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A1 NRCAM MYO10 KLHL23 CDH19	2.95e-06	188	53	5	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.02e-06	189	53	5	d7ed96add29f219183c802895fbff519b627f635
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRS ESR1 LAMA4 SVEP1 PDZRN4	3.10e-06	190	53	5	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A1 KLHL23 LAMA4 LAMC1 SVEP1	3.18e-06	191	53	5	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL4A1 PTPRS LAMC1 CDH19 SVEP1	3.18e-06	191	53	5	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	COL4A1 PTPRS LAMC1 CDH19 SVEP1	3.26e-06	192	53	5	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A1 HOXA6 NRCAM CDH19 ARSI	3.35e-06	193	53	5	b2abe939027a69b60d83a28d4d4cc53ba1dee4c5
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A1 HOXA6 NRCAM CDH19 ARSI	3.35e-06	193	53	5	87ce81ff5b27d9c4300826d76ff5a62e9c408d5d
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM LAMA4 LAMC1 GRIA3 SVEP1	3.35e-06	193	53	5	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A1 HOXA6 NRCAM CDH19 ARSI	3.35e-06	193	53	5	d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRCAM LAMA4 LAMC1 GRIA3 SVEP1	3.35e-06	193	53	5	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRS MYO10 LAMA4 LAMC1 SVEP1	3.35e-06	193	53	5	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRS MYO10 LAMA4 LAMC1 SVEP1	3.35e-06	193	53	5	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	critical-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	COL4A1 NRCAM MYO10 LAMA4 CDH19	3.35e-06	193	53	5	6be11fef87af04ee7a3cc223882ccd4077caded9
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	COL4A1 PTPRS LAMC1 CDH19 SVEP1	3.35e-06	193	53	5	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A1 HOXA6 NRCAM CDH19 ARSI	3.35e-06	193	53	5	41ea268e7697101fe70d8ef1045f3a43b9311739
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	PTPRS MYO10 LAMA4 LAMC1 SVEP1	3.35e-06	193	53	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRS MYO10 LAMA4 LAMC1 SVEP1	3.43e-06	194	53	5	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRS ESR1 LAMA4 SVEP1 PDZRN4	3.43e-06	194	53	5	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL4A1 LAMC1 CDH19 SVEP1 PDZRN4	3.43e-06	194	53	5	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL4A1 DLL4 MYO10 LAMA4 LAMC1	3.43e-06	194	53	5	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL4A1 DLL4 MYO10 LAMA4 LAMC1	3.43e-06	194	53	5	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	3'-Distal_airway-Mesenchymal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A1 HOXA6 NRCAM CDH19 ARSI	3.43e-06	194	53	5	f5e3e675187afb6efa774f2a8d685efcf813de82
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRS ESR1 LAMA4 SVEP1 PDZRN4	3.52e-06	195	53	5	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL4A1 PTPRS LAMC1 CDH19 SVEP1	3.52e-06	195	53	5	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 LAMA4 LAMC1 GRIA3 SVEP1	3.61e-06	196	53	5	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NRCAM GRIA3 CDH19 KIF13A SHISA7	3.61e-06	196	53	5	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NRCAM GRIA3 CDH19 KIF13A SHISA7	3.61e-06	196	53	5	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL4A1 PTPRS LAMC1 CDH19 PDZRN4	3.61e-06	196	53	5	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A1 NRCAM MYO10 LAMA4 SVEP1	3.70e-06	197	53	5	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NRCAM KLHL23 CDH19 PDZRN4	3.70e-06	197	53	5	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 PTPRS LAMA4 LAMC1 SVEP1	3.70e-06	197	53	5	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	COL4A1 PTPRS LAMA4 LAMC1 SVEP1	3.70e-06	197	53	5	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	5'-Adult-Appendix-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 PTPRS LAMA4 LAMC1 SVEP1	3.70e-06	197	53	5	b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NRCAM KLHL23 CDH19 PDZRN4	3.70e-06	197	53	5	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	COL4A1 PTPRS LAMA4 LAMC1 SVEP1	3.70e-06	197	53	5	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	COL4A1 PTPRS LAMA4 LAMC1 SVEP1	3.70e-06	197	53	5	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRCAM PTPRS LAMA4 LAMC1 SVEP1	3.79e-06	198	53	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	NRCAM PTPRS LAMA4 LAMC1 SVEP1	3.79e-06	198	53	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A1 HOXC5 LAMA4 LAMC1 SVEP1	3.89e-06	199	53	5	36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 LAMA4 CDH19 SVEP1 PDZRN4	3.89e-06	199	53	5	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A1 MYO10 LAMA4 ARSI SVEP1	3.89e-06	199	53	5	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A1 MYO10 LAMA4 ARSI SVEP1	3.89e-06	199	53	5	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PTPRS MYO10 LAMA4 LAMC1 SVEP1	3.89e-06	199	53	5	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PTPRS MYO10 LAMA4 LAMC1 SVEP1	3.89e-06	199	53	5	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	medial-mesenchymal-Pericyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	bbda454260016be92b539e220ecf7bcbbc6139e4
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A1 NRCAM LAMA4 ARSI SVEP1	3.98e-06	200	53	5	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A1 NRCAM LAMA4 ARSI SVEP1	3.98e-06	200	53	5	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 PTPRS LAMA4 SVEP1 PDZRN4	3.98e-06	200	53	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	medial-mesenchymal-Pericyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	f36d7cb6345daccebf76997f998e35d959b59452
ToppCell	distal-mesenchymal-Pericyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	fe31287cfb51d45643bdedbaa5efc03ed87263c6
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	medial-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	9820fb4f6efcdfc6de937ef2302a98b48426baa3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	distal-mesenchymal-Pericyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A1 NRCAM MYO10 KLHL23 CDH19	3.98e-06	200	53	5	867935701fac71a3fe01578362da0676f959736c
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A1 MYO10 LAMA4 ARSI SVEP1	3.98e-06	200	53	5	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NRCAM KLHL23 LAMA4 CDH19	3.98e-06	200	53	5	f9bc22ff17bb1c751e6b05bca3f403836f33459a
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 NRCAM KLHL23 LAMA4 CDH19	3.98e-06	200	53	5	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRS ESR1 LAMA4 SVEP1 PDZRN4	3.98e-06	200	53	5	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	NRCAM LAMA4 LAMC1 ARSI SVEP1	3.98e-06	200	53	5	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A1 LAMA4 LAMC1 SVEP1 PDZRN4	3.98e-06	200	53	5	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NRCAM BTBD7 CEP41 DNAH6	2.54e-05	143	53	4	cc396b81a5e47d78c2d1cb49d682391376b63476
ToppCell	Control-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	COL4A1 NRCAM MYO10 CDH19	3.84e-05	159	53	4	6f50c381cd8a26a5a90bf0ce909713cea96910d7
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 DNAH9 SVEP1 PDZRN4	3.94e-05	160	53	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRTM1 DNAH9 SVEP1 PDZRN4	3.94e-05	160	53	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
Drug	6-methylenetestosterone acetate	MTA2 MTA1 MTA3	2.24e-07	6	52	3	CID000159323
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ELOVL4 HOXC5 MTA1 ABHD17B PTPRS BTBD7 ESR1	3.14e-07	197	52	7	2328_DN
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	HOXC5 MTA1 ABHD17B MYO10 BTBD7 ESR1	5.85e-06	198	52	6	3313_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A	COL4A1 MTA1 LAMA4 GRIA3 KIF13A LILRB1	5.85e-06	198	52	6	5984_UP
Drug	2,4-bis(bromomethyl)estrone methyl ether	ESR1 G6PD	1.53e-05	3	52	2	CID000191277
Drug	phenestrol	ESR1 G6PD	3.06e-05	4	52	2	CID000161290
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MTA2 ZZZ3 BTBD7 ESR1 PKP1	4.65e-05	173	52	5	4458_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	ELOVL4 MTA1 ESR1 FECH IGSF1	7.08e-05	189	52	5	7002_UP
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MTA1 MYO10 BTBD7 ESR1 PCSK7	7.44e-05	191	52	5	7438_DN
Drug	borate	MTA2 HOXA6 HOXC5 MTA1	7.46e-05	98	52	4	CID000007628
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	HOXA6 MTA1 CLTCL1 ESR1 LAMA4	7.82e-05	193	52	5	4205_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ELOVL4 HOXC5 MTA1 ESR1 PCSK7	8.01e-05	194	52	5	2863_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	CEP41 LAMA4 KIF13A SVEP1 F13B	8.41e-05	196	52	5	5627_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ABHD17B PTPRS BTBD7 ESR1 KIF13A	8.41e-05	196	52	5	2315_DN
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A	NRCAM ZFR2 ESR1 LAMA4 SVEP1	8.61e-05	197	52	5	3143_UP
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	MTA1 PTPRS PCSK7 IGSF1 SVEP1	8.61e-05	197	52	5	3247_UP
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; HL60; HT_HG-U133A	NRCAM NFATC1 ENPP1 ESR1 PKP1	8.82e-05	198	52	5	6129_UP
Drug	Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A	NRCAM ESR1 PKP1 LAMA4 GRIA3	8.82e-05	198	52	5	3033_UP
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	MTA2 HOXC5 MTA1 PTPRS SVEP1	8.82e-05	198	52	5	1507_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	COL4A1 MTA2 MTA1 LAMA4 SVEP1	8.82e-05	198	52	5	2634_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	MTA2 NFATC1 PTPRS ESR1 ARHGAP12	8.82e-05	198	52	5	6196_DN
Drug	Calcort	NFATC1 LAMA4 LAMC1	8.96e-05	38	52	3	CID000026709
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A	MTA2 NFATC1 LAMA4 GRIA3 SVEP1	9.25e-05	200	52	5	3056_UP
Drug	Bretylium tosylate [61-75-6]; Up 200; 9.6uM; HL60; HT_HG-U133A	MTA2 HOXA6 ESR1 LRTM1 SVEP1	9.25e-05	200	52	5	3057_UP
Drug	N,N'-diphenyl-4-phenylenediamine	ESR1 G6PD	1.07e-04	7	52	2	ctd:C004845
Drug	1-dodecanoyllysolecithin	ENPP1 PCSK7	1.07e-04	7	52	2	CID000460605
Disease	interleukin 7 measurement	LILRA1 CDH19 LILRB1	5.81e-05	45	49	3	EFO_0008189
Disease	Endometrioma	MTA2 RASGRP1 MTA1 ENPP1	1.49e-04	161	49	4	C0269102
Disease	Endometriosis	MTA2 RASGRP1 MTA1 ENPP1	1.49e-04	161	49	4	C0014175
Disease	lymphangioleiomyomatosis (is_marker_for)	ESR1 RICTOR	1.76e-04	12	49	2	DOID:3319 (is_marker_for)
Disease	Anemia, Hemolytic, Acquired	COL4A1 G6PD	2.08e-04	13	49	2	C0002879
Disease	Anemia, Hemolytic	COL4A1 G6PD	2.08e-04	13	49	2	C0002878
Disease	Anemia, Microangiopathic	COL4A1 G6PD	2.08e-04	13	49	2	C0002889
Disease	Microangiopathic hemolytic anemia	COL4A1 G6PD	2.08e-04	13	49	2	C0221021
Disease	Migraine Disorders	COL4A1 ESR1	2.08e-04	13	49	2	C0149931
Disease	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	LILRA1 LILRB1	2.80e-04	15	49	2	EFO_0008208
Disease	response to ziprasidone	ZP1 ZP4	5.04e-04	20	49	2	GO_0097337
Disease	kidney disease (biomarker_via_orthology)	NFATC1 G6PD	5.56e-04	21	49	2	DOID:557 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	ZZZ3 NRCAM NFATC1 PTPRS LAMC1 PDZRN4	1.04e-03	702	49	6	C0009402

Protein segments in the cluster

Peptide	Gene	Start	Entry
YSTYSQAAAQQGYSA	EWSR1	6	Q01844
NYSYRGSVVYQCNAG	CSMD2	2731	Q7Z408
LTGNVDYYTYDNCDG	ARSI	171	Q5FYB1
NYDNYRRAYGECTDF	RASGRP1	336	O95267
RDSYQQCHIVGAYSY	CEP41	181	Q9BYV8
YRVICSDNYYGDNCS	DLL4	171	Q9NR61
CHGRGTCNYYANAYS	COL4A1	1616	P02462
GEYDLYYSSSTIECN	PDZRN4	641	Q6ZMN7
YRVGDYVYFENSSSN	MTA2	6	O94776
SYVAGQYDDAASYQR	G6PD	106	P11413
NYGSASEVQASRYCY	HOXC5	26	Q00444
AAIYGCTYAAITAQY	LRTM1	306	Q9HBL6
ACNRASYEYGASCFY	HOXA6	66	P31267
SSAVYQCNASNEYGY	NRCAM	426	Q92823
SYNAGYSYICQSVDY	ELOVL4	101	Q9GZR5
ATGSSVEYRCNEYYL	F13B	416	P05160
ATNTQNYATYREGYN	GRIA3	871	P42263
NCNYDGYANSIYTVT	PCSK7	336	Q16549
ETRYCAVCNDYASGY	ESR1	181	P03372
SCNSEASSYESNYSY	NFATC1	181	O95644
YRCSVGTYNSSGAYR	MYO10	1121	Q9HD67
YYSFNYEGIARNLSC	ENPP1	466	P22413
DCNFSYTSSRDAFGY	RICTOR	1316	Q6R327
DSSGRCYYYNRGTQE	ARHGAP12	276	Q8IWW6
YVDGYRCQNAYIATQ	PTPRS	1451	Q13332
ACVAYYGAFTAQYRQ	DNAH6	3001	Q9C0G6
TVGAEDSGNYSCIYY	IGSF1	931	Q8N6C5
GYRGSCTYDKVQSYN	KLHL23	426	Q8NBE8
SYSQQGYGCESKLYS	BTBD7	31	Q9P203
PSEARQCDYTGQYYC	DEF8	291	Q6ZN54
QYYSGSCENTYSKAN	LAMC1	176	P11047
GLCCGYQSTFSQYSY	DNAH9	1001	Q9NYC9
CSTTGSSLNAIYRYY	FECH	196	P22830
SQYYETYVCENAGSG	CDH19	471	Q9H159
SAQYANFTGCISNAY	LAMA4	1361	Q16363
SDYSSSYQDVACYGT	KIF13A	1416	Q9H1H9
YRVGDYVYFENSSSN	MTA3	6	Q9BTC8
DNYNYGTTSRSSYYS	PKP1	76	Q13835
QECYHSNGQSYRGTY	LPAL2	26	Q16609
YGGQYRCSGAYNLSS	LILRA1	291	O75019
YRCYYGSDTAGRSES	LILRB1	96	Q8NHL6
QYDATFNCSTGSYRF	SHISA7	91	A6NL88
YRVGDYVYFENSSSN	MTA1	6	Q13330
FYAGSTVTYQCNNGY	SVEP1	1706	Q4LDE5
SRINCNIFSYDYSGY	ABHD17B	116	Q5VST6
ENAYYDSSVVGRYCE	CLTCL1	896	P53675
GSRDIAAYCNYTQYQ	TAS1R3	121	Q7RTX0
TYQDSYSYGQSAAAR	ZFR2	86	Q9UPR6
YYGNTATVQCFRDGY	ZP1	271	P60852
RDYCVSQGTSYNYLD	ZZZ3	881	Q8IYH5
YSSEEVNSCYYGNTV	ZP4	171	Q12836
PYQCQYCEYRSADSS	ZFY	571	P08048
NYTIYCNYSTTSDRL	TRAV39	36	A0A0B4J263